Display Settings:

Format

Send to:

Choose Destination
Science. 1997 Oct 3;278(5335):117-20.

Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations.

Author information

  • 1Center for Immunotherapy of Cancer and Infectious Diseases, MC1601, University of Connecticut School of Medicine, Farmington, CT 06030, USA.

Erratum in

  • Science 1999 Feb 19;283(5405):preceding 1119.

Abstract

Immunotherapy of mice with preexisting cancers with heat shock protein preparations derived from autologous cancer resulted in retarded progression of the primary cancer, a reduced metastatic load, and prolongation of life-span. Treatment with heat shock protein preparations derived from cancers other than the autologous cancer did not provide significant protection. Spontaneous cancers (lung cancer and melanoma), chemically induced cancers (fibrosarcoma and colon carcinoma), and an ultraviolet radiation-induced spindle cell carcinoma were tested, and the results support the efficacy of autologous cancer-derived heat shock protein-peptide complexes in immunotherapy of cancers without the need to identify specific tumor antigenic epitopes.

PMID:
9311915
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire
    Loading ...
    Write to the Help Desk